TBD

Scientific Review Officer

Reporting Avenues for Concerns Related to Integrity or Fairness

The Innovations in Nanosystems and Nanotechnology (INN) study section reviews applications focused on the fundamental development of new enabling materials that take advantage of the unique properties of nanomaterials towards biomedical applications. These materials may exhibit novel advances in chemistry, biology, materials, or physics that advance gene and drug delivery, imaging/diagnostic approaches, or technology development. Novel nanotechnology development may overcome challenges in therapeutic delivery, diagnosis, biodistribution, or overcoming biological barriers.

Review Dates

Topics


  • Design, synthesis, and development of novel nanostructures, nanodevices, nanobiologics, and nanosystems for biomedical applications.
  • Multifunctional nanoparticles in imaging, sensing, targeted drug/gene delivery and theranostics.
  • Biomaterials and/or bioengineered materials, such as extracellular vesicles, engineered exosomes, and recombinant protein-based materials.
  • Mathematical or computational approaches for the advancement of nanotechnology in biomedical applications.
  • Studies of the unique properties of nanomaterials for biomedical applications.
  • Biocompatibility and toxicities associated with nanomaterials. 

Shared Interests and Overlaps

There are shared interests in nano-therapeutics with Drug and Biologic Therapeutic Delivery (DBTD) and BBBT(81). Applications focused on unique features of multifunctional nanoparticles, nanobiomaterials, DNA scaffolds, liposomes, micelles, vesicles, and biomimetic membranes as delivery and targeting platforms as well as their synthesis, engineering, chemical properties, and/or cellular processing are reviewed in INN.  Applications that focus on biological delivery and targeting issues involving the use of nanocarriers for small molecules and biologics are reviewed in DBTD or for nucleic acids are reviewed in BBBT (81). 

There are shared interests in nanosystem/nanotechnology development with Drug and Biological Disposition and Toxicity (DBDT). Applications that focus on the development of novel nanotechnology are reviewed in INN.  Applications that focus on the disposition, safety and toxicity of delivery agents are reviewed in DBDT.

There are shared interests in nanobiomaterials with Biomaterials and Biointerfaces Study Section (BMBI). Applications that focus on the biocompatibility and toxicities associated with nanomaterials are reviewed in INN.  Applications that address the use of nanomaterial-based approaches for tissue engineering are reviewed in BMBI.

There are shared interests in biosensing development with Instrumentation and Systems Development (ISD). Applications that emphasize developing biosensing or technologies involving the development of novel nanostructures or functionalize nanoparticles are reviewed in INN. Applications that emphasize developing biosensing or technologies that are more device-based are reviewed in ISD.

There are shared interests in area of drug delivery using nanomaterials with Advancing Therapeutics A (ATA) and MCST (81). Applications that focus on the fundamental development, engineering, and rational design of new classes of multifunctional nanoparticle systems and combination therapy using novel nanoparticles are reviewed in INN.  Applications that emphasize late-stage preclinical development of therapeutic nanoparticles are reviewed in ATA for cancer or MCST (81) for other biological systems.

There are shared interests in nanomaterials with Cellular and Molecular Technologies (CMT). Applications that focus on material development and characterization are reviewed in INN.  Applications that focus on the use of nanomaterials to address cellular and molecular processes are reviewed in CMT.

There are shared interests in development of polymeric, supramolecular and nanomaterial entities with Chemical Synthesis & Biosynthesis (CSB). Applications that emphasize the development of higher-level nanostructures, nanodevices, nano-biologics, or biomaterials customized for specific biomedical applications are reviewed in INN. Applications that propose new basic synthetic chemistry strategies are reviewed in CSB. 

There are shared interests with Vaccines Against Infectious Diseases (VID) in developing novel vaccine nanomaterials.  Applications that emphasize the use of existing nanomaterials in a vaccine or on testing the efficacy of a vaccine-related nanomaterial may be reviewed in VID. Applications that emphasize the design, synthesis, and development of nanomaterials may be reviewed in INN.